Adherence therapy (n = 204) | Health education (n = 205) | Adherence therapy – Health education1 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Valid n | Mean | (SD) | Valid n | Mean | (SD) | Unadjusted comparisons | Baseline-adjusted comparisons | |||
Mean difference | 95% confidence interval | Mean difference | 95% confidence interval | |||||||
SF-36 MCS | ||||||||||
Baseline | 191 | 38.39 | (11.22) | 195 | 40.11 | (12.15) | -1.72 | -4.14, 0.54 | na | na |
1 year follow-up | 175 | 40.24 | (11.97) | 192 | 41.32 | (11.49) | -1.08 | -3.43, 1.42 | -0.33 | -2.41, 1.79 |
SF-36 utilities and QALYs | ||||||||||
Baseline utility | 191 | 0.66 | (0.12) | 192 | 0.68 | (0.13) | -0.02 | -0.04, 0.01 | na | na |
1 year follow-up utility | 177 | 0.68 | (0.14) | 190 | 0.69 | (0.13) | -0.01 | -0.04, 0.02 | -0.005 | -0.03, 0.02 |
1 year QALY gain | 166 | 0.67 | (0.11) | 179 | 0.68 | (0.12) | -0.01 | -0.04, 0.01 | -0.002 | -0.01, 0.01 |
EQ5D utilities and QALYs | ||||||||||
Baseline utility | 196 | 0.67 | (0.30) | 198 | 0.69 | (0.28) | -0.02 | -0.08, 0.03 | na | na |
1 year follow-up utility | 174 | 0.68 | (0.31) | 193 | 0.74 | (0.26) | -0.06 | -0.12, -0.003 | -0.04 | -0.09, 0.01 |
1 year QALY gain | 170 | 0.67 | (0.26) | 188 | 0.72 | (0.23) | -0.05 | -0.10, 0.01 | -0.02 | -0.05, 0.01 |